TSH-Suppressive Therapy: A Thorny Issue

Thyroid stimulating hormone (TSH)-suppressive therapy with levothyroxine is a cornerstone of thyroid carcinoma follow-up therapy, but the achievement of therapeutic goals must be balanced against L-T4 side effects. We describe the case of a 64-year-old cardiopathic patient with papillary thyroid car...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldini, Itala Marina, Cocino, Cristina, Seghezzi, Sonia, Cappellini, Maria Domenica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346897/
https://www.ncbi.nlm.nih.gov/pubmed/30755925
http://dx.doi.org/10.12890/2016_000547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346897/
https://www.ncbi.nlm.nih.gov/pubmed/30755925
http://dx.doi.org/10.12890/2016_000547

Ejemplares similares